Dr. Lawrence Rosenberg
April 2016Research at the Lady Davis Institute

Landmark clinical trial under way for type 1 diabetes treatment

Patients with long-standing type 1 diabetes are undergoing a clinical trial for a therapeutic approach that combines an agent for stimulating the growth of insulin-secreting cells in the pancreas, along with a drug to prevent the autoimmune system from rejecting the newly formed cells.

READ MORE →
Dr. Samy Suissa
Research at the Lady Davis InstituteSpring 2015

Link found between pain reliever
and hypoglycemia

Tramadol, a weak opioid for treating moderate to moderately severe pain, can be linked in some cases to an increased risk of hospitalization for hypoglycemia, concludes a study by a team of epidemiologists in the Lady Davis Institute at the JGH.

READ MORE →